Neuropsychiatric Symptoms and Alzheimer's Disease Biomarkers Predict Driving Decline: Brief Report

We examined whether neuropsychiatric symptoms (NPS) interact with cerebrospinal fluid (CSF) biomarkers (amyloid-β(42) [Aβ(42)], tau, phosphorylated tau(181) [ptau(181)], tau/Aβ(42), and ptau(181)/Aβ(42)) of Alzheimer's disease pathology to predict driving decline among cognitively-normal older...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Alzheimers Dis
Asıl Yazarlar: Babulal, Ganesh M., Stout, Sarah H., Head, Denise, Holtzman, David M., Fagan, Anne M., Morris, John C., Roe, Catherine M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5555740/
https://ncbi.nlm.nih.gov/pubmed/28453487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-170067
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller